Press Releases

Mar 27, 2024
Businesswire

KeifeRx Announces the Appointments of Dan Feehan and Alison Finger to Board of Directors
View Article

 

Jan 8, 2024
PR Newswire

KeifeRx Expands Exclusive Licensing Agreement with Georgetown University to Include Multiple Disease Indications for Portfolio of Novel Tyrosine Kinase Inhibitors
View Article

 

Feb 14, 2023
PR Newswire

KeifeRx Appoints Garrett Vygantas, MD, MBA, to Board of Directors
View Article

 

Jan 26, 2023
PR Newswire

KeifeRx to Present at the BIO CEO & Investor Conference
View Article

 

Nov 03, 2022
PR Newswire

KeifeRx to Present at BioFuture 2022
View Article

 

JUNE 2, 2022
PR Newswire

KeifeRx to Present at BIO International Convention 2022
View Article

 

December 8, 2021
PR Newswire

KeifeRx Completes $6 Million Series A Financing and Enhances Board of Directors
View Article

 

July 20, 2021
PR Newswire

KeifeRx Receives FDA Acceptance of Investigational New Drug for Phase 3 Study of Nilotinib BE in Early Alzheimer’s Disease
View Article

 

March 31, 2021
PR Newswire

KeifeRx Builds Leadership Team with Announcement of Chris Hoyt as Chief Executive Officer
View Article

 

May 29, 2020

Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial Georgetown University Medical Center
View Article

 

October 8, 2019

Georgetown Offers Multiple Clinical Trials for People with Lewy Body Dementia Georgetown University
View Article

 

September 27, 2018

Cures Within Reach Funds Huntington’s Disease Clinical Trial with Nilotinib at Georgetown Georgetown University
View Article

 

July 16, 2017

Agent Clears Toxic Proteins, Reduces Inflammation and Improves Cognition in Neurodegeneration Models Georgetown University
View Article

 

February 27, 2017

Georgetown Announces Phase II Clinical Trial of Nilotinib for Parkinson’s Disease Georgetown University
View Article

 

September 29, 2016

Georgetown receives FDA clearance to conduct clinical trial with nilotinib in Alzheimer’s disease Georgetown University
View Article

Media

January 26, 2022
Fox Business

Keiferx CEO on new method for treating Alzheimer’s, neurodegenerative disease
View Article

 

January 19, 2022
The Bio Report

Disposing Toxic Proteins to Treat Neurodegenerative Diseases
View Article

 

November 12, 2021
Genetic Engineering & Biotech News

Parkinson’s Disease Trial Reveals Defects in Blood-Brain Barrier
View Article

 

November 12, 2021
Georgetown Medical Center

Vascular defects appear to underlie the progression of Parkinson’s disease
View Article

 

October 20, 2020
Medscape Medical News

CML Drug Nilotinib Shows Early Effects in Alzheimer’s Disease
View Article

 

December 16, 2019
Jama Network

Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease – Audio
View Article

 

October 22, 2019
Science Daily

Novel agent flips on garbage disposal in neurons, eliminating toxic brain proteins in mice
View Article

 

June 4, 2019
TrialSite News

Could a Pfizer Cancer Drug be a Treatment for a Form of Dementia? Georgetown University Launches Clinical Trial to Find Out
View Article

 

March 13, 2019
MedStar Health News

Researchers Decode How Cancer Drug Works in Brains of Parkinson’s Disease Patients
View Article

 

March 17, 2017
The Science Times

Leukemia Drug Nilotinib Can Cure Parkinson’s, Alzheimer’s & Dementia As Well
View Article

 

March 15, 2017
NPR

Cancer Drug That Might Slow Parkinson’s, Alzheimer’s Headed For Bigger Tests
View Article

 

January 26, 2017
Alzheimer’s News Today

Georgetown to Lead Phase 2 Study of Cancer Drug in Treating Alzheimer’s
View Article

OCTOBER 10, 2016 THE CONVERSATION
Nobel prize – winning autophagy research laid groundwork for potential Parkinson’s treatment View Article

OCTOBER 4, 2016 STAT NEWS
Autophagy: Eating up Alzheimer’s disease? View Article

OCTOBER 3, 2016 LOS ANGELES TIMES
Japanese scientist Yoshinori Ohsumi wins Nobel Prize in medicine for work on cellular ‘recycling’ View Article

SEPTEMBER 29, 2016 GEORGETOWN UNIVERSITY
Georgetown receives FDA clearance to conduct clinical trial with nilotinib in Alzheimer’s disease View Article

SEPTEMBER 29, 2016 ALZHEIMER’S DRUG DISCOVERY FOUNDATION
New Clinical Trial Will Test Cancer Drug as Alzheimer’s Treatment View Article

AUGUST 10, 2016 THE GUARDIAN
New research hints at pattern of Alzheimer’s spread in the brain View Article

AUGUST 1, 2016 THE PHARMA LETTER
AAIC 2016 showcases exciting Alzheimer’s developments View Article

JULY 18, 2016 PARKINSON’S NEWS TODAY
Cancer drug raises dopamine levels, eases Parkinson’s symptoms in early study in patients View Article

JULY 15, 2016 NEUROLOGYADVISOR
Leukemia drug may have benefits for Parkinson’s disease View Article

JULY 14, 2016 DRUG DISCOVERY & DEVELOPMENT
Cancer drug could improve Parkinson’s symptoms View Article

JULY 13, 2016 EUROPEAN PHARMACEUTICAL REVIEW
Collaboration to explore nilotinib as a potential treatment for Parkinson’s View Article

JULY 13, 2016 FIERCEBIOTECH
Novartis cancer drug to be tested for Parkinson’s disease View Article

JULY 11, 2016 BIOPHARMA DIVE
Cancer drug could benefit Parkinson’s patients, study shows View Article

OCTOBER 21, 2015 MEDSCAPE
Cancer drug shows promise in Parkinson’s dementia View Article

OCTOBER 21, 2015 FORBES
Could a cancer drug reverse Parkinson’s disease? View Article

OCTOBER 20, 2015 WTTG FOX
Nilotinib/Parkinson’s study View Article

OCTOBER 20, 2015 NEW SCIENTIST
Drug reversed my Parkinson’s symptoms and let me read again View Article

OCTOBER 19, 2015 HUFFINGTON POST
Parkinson’s drug trial branded ‘life-changing’ after helping patients walk and talk again View Article

OCTOBER 19, 2015 YAHOO NEWS
Cancer drug shows promise against Parkinson’s disease View Article

OCTOBER 19, 2015 FORTUNE
Parkinson’s patients show improvement after taking cancer drug View Article

OCTOBER 19, 2015 EUROPEAN PHARMACEUTICAL REVIEW
Nilotinib improved cognition and motor skills in Parkinson’s trial View Article

OCTOBER 19, 2015 AUDIO STORY
Local researchers working on groundbreaking treatment for Parkinson’s – Pt 2 View Article

OCTOBER 19, 2015 AUDIO STORY
Local researchers working on groundbreaking treatment for Parkinson’s – Pt 1 View Article

OCTOBER 19, 2015 DIGITAL JOURNAL
Cancer drug shows promise with reversing Parkinson’s disease View Article

OCTOBER 19, 2015 RTT NEWS
Blood cancer drug giving hopes for Parkinson’s patients View Article

OCTOBER 19, 2015 HNGN
Cancer drug shows promise in reversing Parkinson’s and dementia View Article

OCTOBER 19, 2015 MEDICAL NEWS TODAY
Man walks again as cancer drug is trialled for Parkinson’s View Article

OCTOBER 19, 2015 WTOP ONLINE
Local researchers working on groundbreaking treatment for Parkinson’s View Article

OCTOBER 19, 2015 NBC4
Cancer drug could be medical breakthrough for Parkinson’s disease patients View Article

OCTOBER 19, 2015 POURQUOI DOCTEUR
Maladie de Parkinson : un anti-cancéreux produit des résultats inespérés View Article

OCTOBER 19, 2015 PSYCHIATRY ADVISOR
Cancer drug improves Parkinson’s symptoms and progression View Article

OCTOBER 18, 2015 MEDICAL XPRESS
Cancer drug improved cognition and motor skills in small Parkinson’s clinical trial View Article

OCTOBER 18, 2015 CTV NEWS
Cancer drug shows promise for reversing symptoms of Parkinson’s disease View Article

OCTOBER 18, 2015 THE INDEPENDENT
Parkinson’s patients ‘walk and talk again’ after receiving cancer drug in trial View Article

OCTOBER 18, 2015 DAILY MAIL
Parkinson’s victims ‘brought back to life’: Cancer drug’s amazing effect echoes Awakenings film View Article

OCTOBER 17, 2015 BLOOMBERG
Novartis cancer drug shows promise as treatment for Parkinson’s View Article

OCTOBER 17, 2015 NBC NEWS
Cancer drug helps Parkinson’s patients View Article

OCTOBER 17, 2015 HEALTHLINE NEWS
Cancer drug offers new hope for Parkinson’s and Alzheimer’s diseases View Article

OCTOBER 17, 2015 NPR
Can a cancer drug reverse Parkinson’s disease and dementia? View Article

OCTOBER 17, 2015 SCIENCE DAILY
Cancer drug improved cognition, motor skills in small Parkinson’s clinical trial View Article

OCTOBER 17, 2015 NPR HOURLY NEWS UPDATE
Cancer drug reverses Parkinson’s View Article

OCTOBER 17, 2015 GEORGETOWN UNIVERSITY MEDICAL CENTER
Researchers report first therapy appearing to reverse decline in Parkinson’s View Article

OCTOBER 17, 2015 BLOOMBERG RADIO
Nilotinib for Parkinson’s View Article

OCTOBER 17, 2015 NEW SCIENTIST
People with Parkinson’s walk again after promising drug trial View Article

NOVEMBER 14, 2014 THE HOYA
Researchers publish new findings on Alzheimer’s View Article

NOVEMBER 9, 2014 STATESMAN JOURNAL
Is tau the ‘how’ behind Alzheimer’s? View Article

NOVEMBER 4, 2014 ALZHEIMER’S NEWS TODAY
Tau protein leads to neuronal death in Alzheimer’s View Article

NOVEMBER 3, 2014 MEDICAL NEWS
Tau proteins spur neuron death in Alzheimer’s disease View Article

NOVEMBER 2, 2014 BUSINESS STANDARD
Tau proteins trigger brain cell death in Alzheimer’s View Article

FEB 4, 2013
Movement Disorders: Ask Dr. Fernando Pagan View Article